Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q9BLQ5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 24 | 28 | PF00656 | 0.598 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.425 |
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.279 |
CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.567 |
CLV_PCSK_FUR_1 | 113 | 117 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.536 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.295 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 238 | 240 | PF00082 | 0.527 |
CLV_PCSK_PC1ET2_1 | 115 | 117 | PF00082 | 0.523 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.578 |
CLV_PCSK_PC1ET2_1 | 161 | 163 | PF00082 | 0.405 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.431 |
DOC_CKS1_1 | 218 | 223 | PF01111 | 0.531 |
DOC_CYCLIN_yClb3_PxF_3 | 102 | 110 | PF00134 | 0.424 |
DOC_USP7_UBL2_3 | 127 | 131 | PF12436 | 0.549 |
DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.463 |
DOC_WW_Pin1_4 | 217 | 222 | PF00397 | 0.540 |
LIG_14-3-3_CanoR_1 | 120 | 129 | PF00244 | 0.401 |
LIG_14-3-3_CanoR_1 | 4 | 14 | PF00244 | 0.531 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.490 |
LIG_eIF4E_1 | 78 | 84 | PF01652 | 0.521 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.611 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.673 |
LIG_FHA_2 | 121 | 127 | PF00498 | 0.337 |
LIG_FHA_2 | 136 | 142 | PF00498 | 0.419 |
LIG_FHA_2 | 218 | 224 | PF00498 | 0.498 |
LIG_GBD_Chelix_1 | 83 | 91 | PF00786 | 0.519 |
LIG_LIR_Gen_1 | 126 | 136 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 138 | 148 | PF02991 | 0.555 |
LIG_LIR_Gen_1 | 75 | 85 | PF02991 | 0.530 |
LIG_LIR_Gen_1 | 8 | 18 | PF02991 | 0.581 |
LIG_LIR_Nem_3 | 126 | 132 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 42 | 48 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 86 | 91 | PF02991 | 0.461 |
LIG_SH2_CRK | 129 | 133 | PF00017 | 0.440 |
LIG_SH2_CRK | 88 | 92 | PF00017 | 0.446 |
LIG_SH2_SRC | 199 | 202 | PF00017 | 0.580 |
LIG_SH2_STAP1 | 140 | 144 | PF00017 | 0.412 |
LIG_SH2_STAP1 | 48 | 52 | PF00017 | 0.503 |
LIG_SH2_STAT3 | 3 | 6 | PF00017 | 0.655 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.599 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 233 | 236 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.534 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.663 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.418 |
LIG_TYR_ITAM | 75 | 91 | PF00017 | 0.528 |
LIG_TYR_ITIM | 76 | 81 | PF00017 | 0.440 |
MOD_CK2_1 | 217 | 223 | PF00069 | 0.469 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.458 |
MOD_PKA_2 | 210 | 216 | PF00069 | 0.653 |
MOD_PKB_1 | 118 | 126 | PF00069 | 0.335 |
MOD_Plk_1 | 174 | 180 | PF00069 | 0.484 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.409 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.516 |
MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.461 |
MOD_ProDKin_1 | 217 | 223 | PF00069 | 0.537 |
TRG_DiLeu_BaEn_1 | 79 | 84 | PF01217 | 0.513 |
TRG_DiLeu_BaLyEn_6 | 161 | 166 | PF01217 | 0.465 |
TRG_ENDOCYTIC_2 | 129 | 132 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.456 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.587 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.471 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.519 |
TRG_ER_diArg_1 | 145 | 147 | PF00400 | 0.436 |
TRG_ER_diArg_1 | 178 | 181 | PF00400 | 0.651 |
TRG_ER_diArg_1 | 237 | 239 | PF00400 | 0.577 |
TRG_Pf-PMV_PEXEL_1 | 164 | 168 | PF00026 | 0.655 |
TRG_Pf-PMV_PEXEL_1 | 181 | 185 | PF00026 | 0.454 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3B4 | Leptomonas seymouri | 78% | 81% |
A0A0S4J2A8 | Bodo saltans | 46% | 73% |
A0A1X0NL02 | Trypanosomatidae | 61% | 89% |
A0A3S5H594 | Leishmania donovani | 96% | 78% |
A4H3V0 | Leishmania braziliensis | 89% | 97% |
A4HS25 | Leishmania infantum | 96% | 94% |
C9ZY18 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 87% |
E9AK12 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 97% |
V5ATQ3 | Trypanosoma cruzi | 63% | 90% |